Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies-Reference-Cited by-同舟云学术

Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies

Published:2022-09 Issue:9 Volume:109 Page:1638-1652
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Harlow Charli E.^ORCID,Gandawijaya Josan,Bamford Rosemary A.,Martin Emily-Rose,Wood Andrew R.,van der Most Peter J.,Tanaka Toshiko,Leonard Hampton L.,Etheridge Amy S.,Innocenti Federico,Beaumont Robin N.,Tyrrell Jessica,Nalls Mike A.,Simonsick Eleanor M.,Garimella Pranav S.,Shiroma Eric J.,Verweij Niek,van der Meer Peter,Gansevoort Ron T.,Snieder Harold,Gallins Paul J.,Jima Dereje D.,Wright Fred,Zhou Yi-hui,Ferrucci Luigi,Bandinelli Stefania,Hernandez Dena G.,van der Harst Pim,Patel Vickas V.,Waterworth Dawn M.,Chu Audrey Y.,Oguro-Ando Asami,Frayling Timothy M.

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference93 articles.

1. Prevalence of anemia in chronic kidney disease in the United States;Stauffer;PLoS One,2014

2. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis;Hill;PLoS One,2016

3. Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States;St Peter;BMC Nephrol.,2018

4. Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis;Zheng;Front. Pharmacol.,2020

5. Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology;Cases;Nefrologia,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare variant associations with plasma protein levels in the UK Biobank;Nature;2023-10-04

2. EPO rs1617640 A>C is a Protective Factor for Chronic Obstructive Pulmonary Disease: A Case Control Study;Frontiers in Bioscience-Landmark;2023-09-24

3. Increased transferrin protects from thrombosis in Chuvash erythrocytosis;American Journal of Hematology;2023-07-12

4. Observational and Genetic Evidence for Bidirectional Effects Between Red Blood Cell Traits and Diastolic Blood Pressure;American Journal of Hypertension;2023-07-11

5. EPO rs1617640 A>C is a protective factor for chronic obstructive pulmonary disease: a case control study;2022-10-11